Back
Replimune Group 10K Form
Sell
40
REPL
Replimune Group
Last Price:
6.88
Seasonality Move:
7.06%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive REPL News And Ratings
See the #1 stock for the next 7 days that we like better than REPL
REPL Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-48.84M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.87 |
| Price / Book: | 1.02 |
Profitability
| EPS (TTM): | -3.16000 |
|---|---|
| Net Income (TTM): | $-209.96M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Replimune Group Earnings Forecast
Key Replimune Group Financial Ratios
- The Interest Expense is -2.39% of Operating Income.
- Per Share Earnings over the last 7 years have been positive in 0 years.
Replimune Group Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | REPL |
| CUSIP: | 76029N |
| Website: | replimune.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
REPL Technical Analysis vs Fundamental Analysis
Sell
40
Replimune Group (REPL)
is a Sell
Is Replimune Group a Buy or a Sell?
-
Replimune Group stock is rated a Sell
The current Replimune Group [REPL] share price is $7.01. The Score for REPL is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.